Boston, MA -- (ReleaseWire) -- 02/04/2014 -- Product Synopsis
This report presents the findings from a survey of 102 pharmaceutical regarding their Information and Communications Technology (ICT) investment priorities. The survey investigates the core technologies which pharmaceutical companies are investing in, including the likes of enterprise applications, security, mobility, communications and collaboration, and Cloud Computing.
Introduction and Landscape
Why was the report written?
In order to provide deeper insights into pharmaceutical companies' ICT investment priorities and strategic objectives.
What is the current market landscape and what is changing?
Kable's survey finds that apart from investing in core technologies (such as security, enterprise applications, and IT systems management), many pharmaceutical companies are looking to adopt green IT and virtualization, cloud computing, mobility, and business intelligence solutions.
What are the key drivers behind recent market changes?
Demand for such advanced technologies are increasing amongst pharmaceutical companies as these solutions will help them to reduce their costs, enhance operational efficiencies, achieve sustainability, and improve customer experience.
View Full Report Details and Table of Contents
What makes this report unique and essential to read?
Kable Global ICT Intelligence has invested significant resources in order to interview CIOs and IT managers about their IT investment priorities. Very few IT analyst houses will have interviewed 100+ ICT decision makers in pharmaceutical industry in H2 2012.
Key Features and Benefits
Recognize pharmaceutical companies' strategic objectives with regards to their ICT investments.
Identify pharmaceutical companies' investment priorities based on their budget allocations across core technology categories such as enterprise applications, security, mobility, communications and collaboration, and Cloud Computing, etc.
Learn about the drivers that are influencing pharmaceutical companies' investments in each technology category.
Establish how pharmaceutical companies' IT budgets are currently allocated across various segments within a technology category.
Gain insight into how pharmaceutical companies' plan to change their ICT budget allocations across various segments within a technology category.
Key Market Issues
The demand for security solutions is set to continue, with 87% of survey respondents planning investments in this area in the next two years, owing to the increasing adoption of enterprise mobility and rising data security threats in pharmaceutical companies.
Companies in the pharmaceutical sector are keen to deploy a cost effective supply chain solution in order to streamline their operations.
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Software research reports at Fast Market Research
You may also be interested in these related reports:
- ICT Priorities in Retail Banking - Enterprise ICT investment plans
- ICT priorities in Australia - Enterprise ICT investment plans to 2013
- ICT procurement trends in Pharmaceuticals - Enterprise ICT investment plans
- ICT Priorities in the Media Industry - Enterprise ICT investment plans
- ICT Priorities in medium-sized enterprises - Enterprise ICT investment plans
- ICT priorities in Italy - Enterprise ICT investment plans to 2013
- ICT Priorities in Energy - Enterprise ICT investment plans
- ICT Priorities in Financial Markets - Enterprise ICT investment plans
- ICT Priorities in Healthcare - Enterprise ICT investment plans
- ICT priorities in Finland - Enterprise ICT investment plans to 2013